Kim Chang Hwan, Bae Jung Hoon, Lee Chul Seung, Han Seung-Rim, Lee In Kyu, Lee Dosang, Kang Won Kyung, Kim Ji Hoon, Kye Bong-Hyeon, Cho Hyeon-Min, Oh Seong Taek, Lee Sang Chul, Lee Yoon Suk
Department of General Surgery, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Division of Colorectal Surgery, Department of General Surgery, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
J Minim Invasive Surg. 2021 Sep 15;24(3):128-138. doi: 10.7602/jmis.2021.24.3.128.
The prognostic factors in obstructive colon cancer have not been clearly identified. We aimed to identify the prognostic factor to establish optimal treatment strategy in obstructive colon cancer.
Patients who underwent surgery for primary colon cancer in stages II and III with symptomatic obstruction from 2004 to 2010 in six hospitals were retrospectively collected. Clinicopathological and surgical outcomes were compared between stent insertion and emergent surgery group. Multiple regression analysis and survival curve analysis were used to identify the prognostic factors in symptomatic obstructive colon cancer.
Among 210 patients, 168 patients (80.0%) underwent stent insertion followed by surgery and 42 patients (20.0%) underwent emergent surgery. Laparoscopic approach (55.4% vs. 23.8%, < 0.001) and adequate lymph node (LN) harvest (≥12) (93.5% vs. 69.0%, < 0.001) were significantly higher in stent insertion group. In multiple regression analysis, emergent surgery (hazard ratio [HR], 2.153; 95% confidence interval [CI], 1.031-4.495), vascular invasion (HR, 6.257; 95% CI, 2.784-14.061), and omitting adjuvant chemotherapy (HR, 3.107; 95% CI, 1.394-6.925) were independent poor prognostic factors in 5-year overall survival, and N stage (N1 HR, 3.095; 95% CI, 1.316-7.284; N2 HR, 4.156; 95% CI, 1.671-10.333) was the only poor prognostic factor in 5-year disease-free survival.
In symptomatic obstructive colon cancer, emergent surgery, N stage, vascular invasion, and omission of adjuvant chemotherapy were independent poor prognostic factors. Stent insertion is suggested as the initial treatment for symptomatic obstructive colon cancer, and adjuvant chemotherapy is recommended, especially when vascular invasion or LN metastasis is confirmed.
梗阻性结肠癌的预后因素尚未明确。我们旨在确定预后因素,以制定梗阻性结肠癌的最佳治疗策略。
回顾性收集2004年至2010年在6家医院接受手术治疗的Ⅱ期和Ⅲ期原发性结肠癌伴症状性梗阻的患者。比较支架置入组和急诊手术组的临床病理及手术结果。采用多元回归分析和生存曲线分析来确定症状性梗阻性结肠癌的预后因素。
210例患者中,168例(80.0%)接受支架置入后再手术,42例(20.0%)接受急诊手术。支架置入组的腹腔镜手术入路比例(55.4%对23.8%,P<0.001)和足够的淋巴结清扫(≥12个)比例(93.5%对69.0%,P<0.001)显著更高。在多元回归分析中,急诊手术(风险比[HR],2.153;95%置信区间[CI],1.031 - 4.495)、血管侵犯(HR,6.257;95%CI,2.784 - 14.061)以及未进行辅助化疗(HR,3.107;95%CI,1.394 - 6.925)是5年总生存的独立不良预后因素,而N分期(N1期HR,3.095;95%CI,1.316 - 7.284;N2期HR,4.156;95%CI,1.671 - 10.333)是5年无病生存的唯一不良预后因素。
在症状性梗阻性结肠癌中,急诊手术、N分期、血管侵犯和未进行辅助化疗是独立的不良预后因素。建议将支架置入作为症状性梗阻性结肠癌的初始治疗方法,并且推荐进行辅助化疗,尤其是在确认存在血管侵犯或淋巴结转移时。